The Institute for Precision Health (IPH) at Notre Dame engages scientists, engineers, and clinical practitioners in cross-cutting research, education, and entrepreneurship programs that advance individualized health and wellness. The institute serves its interdisciplinary community by creating opportunities for the development of new discovery-based and hypothesis-driven ideas, supporting the education and training of students, and helping move proven ideas out of the lab and into broader use. IPH also educates the public about the opportunities, challenges, and complexities inherent in health-related research.
The IPH’s research is organized around five main themes: molecular mining, molecular recognition, microbiome and human health, micro- and nanoscale biomedical instrumentation, and point-of-use platforms. Each theme fosters cross-cutting exploration and integration across multiple disease areas and health challenges.
The Notre Dame Institute for Precision Health is led by Director Paul Bohn, Arthur J. Schmitt Professor of Chemical and Biomolecular Engineering and Professor of Chemistry and Biochemistry, who also established and directed the institute’s predecessor, the Advanced Diagnostics & Therapeutics research center. Bohn is a director of the Indiana Consortium for Analytical Science and Engineering (ICASE)–a close working partnership with the top-ranked analytical chemistry programs at Purdue University and Indiana University Bloomington–and is the Director of the Center for Bioanalytic Metrology, a National Science Foundation Phase I Industry-University Cooperative Research Center.
The Institute for Precision Health is a unit of Notre Dame Research.